Gemtuzumab ozogamicin combined with intensive chemotherapy in acute myeloid leukemia patients relapsing after allogenic stem-cell transplantation
Publication date: Available online 6 July 2020Source: Clinical Lymphoma Myeloma and LeukemiaAuthor(s): Alexis Genthon, Eolia Brissot, Florent Malard, Zoe van de Wyngaert, Agnès Bonnin, Anne Banet, Zora Marjanovic, Souhila Ikhlef, Simona Lapusan, Simona Sestilli, Elise Corre, Annalisa Paviglianiti, Rosa Adaeva, Fella M.’Hammedi-Bouzina, Myriam Labopin, Rémy Dulery, Mohamad Mohty, Ollivier Legrand
Source: Clinical Lymphoma Myeloma and Leukemia - Category: Cancer & Oncology Source Type: research
More News: Acute Leukemia | Acute Myeloid Leukemia | Cancer & Oncology | Chemotherapy | Leukemia | Lymphoma | Myeloma | Stem Cell Therapy | Stem Cells | Transplants